Next Article in Journal
Low-Grade Inflammation Is Not Present in Former Obese Males but Adipose Tissue Macrophage Infiltration Persists
Previous Article in Journal
Flavolignans from Silymarin as Nrf2 Bioactivators and Their Therapeutic Applications
Open AccessArticle

Synthesis and Modeling Studies of Furoxan Coupled Spiro-Isoquinolino Piperidine Derivatives as NO Releasing PDE 5 Inhibitors

1
School of Chemical Sciences, SRTM University, Nanded 431606, Maharashtra, India
2
Department of Pharmaceutical Chemistry, Bharati Vidyapeeth College of Pharmacy, Kolhapur 416013, Maharashtra, India
3
Natural and Medical Sciences Research Center, University of Nizwa, P.O. Box 33, Postal Code 616, Birkat Al Mouz, Nizwa, Oman
*
Authors to whom correspondence should be addressed.
Biomedicines 2020, 8(5), 121; https://doi.org/10.3390/biomedicines8050121
Received: 8 March 2020 / Revised: 7 April 2020 / Accepted: 10 April 2020 / Published: 14 May 2020
(This article belongs to the Section Natural Compounds in Biomedicine)
Nitric oxide (NO) is considered to be one of the most important intracellular messengers that play an active role as neurotransmitter in regulation of various cardiovascular physiological and pathological processes. Nitric oxide (NO) is a major factor in penile erectile function. NO exerts a relaxing action on corpus cavernosum and penile arteries by activating smooth muscle soluble guanylate cyclase and increasing the intracellular concentration of cyclic guanosine monophosphate (cGMP). Phophodiesterase (PDE) inhibitors have potential therapeutic applications. NO hybridization has been found to improve and extend the pharmacological properties of the parental compound. The present study describes the synthesis of novel furoxan coupled spiro-isoquinolino-piperidine derivatives and their smooth muscle relaxant activity. The study reveals that, particularly 10d (1.50 ± 0.6) and 10g (1.65 ± 0.7) are moderate PDE 5 inhibitors as compared to Sidenafil (1.43 ± 0.5). The observed effect was explained by molecular modelling studies on phosphodiesterase. View Full-Text
Keywords: nitric oxide; furoxan; PDE 5 inhibitors; spiro-isoquinolino piperidine nitric oxide; furoxan; PDE 5 inhibitors; spiro-isoquinolino piperidine
Show Figures

Figure 1

MDPI and ACS Style

Prabhuling, S.; Tamboli, Y.; Choudhari, P.B.; Bhatia, M.S.; Mohanta, T.K.; Al-Harrasi, A.; Pudukulathan, Z.K. Synthesis and Modeling Studies of Furoxan Coupled Spiro-Isoquinolino Piperidine Derivatives as NO Releasing PDE 5 Inhibitors. Biomedicines 2020, 8, 121.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop